Could a tablespoon of peanut butter help diagnose Alzheimer’s?

| | Health Imaging | Neuroimaging

As neuroimaging technology continues to be researched as a tool for early diagnosis of Alzheimer’s disease, researchers at the University of Florida (UF), Gainesville, have been investigating a much more low-tech alternative requiring only a ruler and a dab of peanut butter.

UF graduate student Jennifer Stamps devised an odor detection test that revealed patients in the early stages of Alzheimer’s disease had a harder time recognizing the smell of peanut butter using only their left nostril, requiring it to be much closer to their noses, but had no problem when using their right nostril.

For more, check out the video and link below:

UF researchers find that ‘peanut butter’ test can help diagnose Alzheimer’s dis…

Related Content

Experts update AUC for amyloid, tau PET imaging for first time in more than a decade
Infamous kidnapping survivor shares brain scan findings detailing the impact of her trauma
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care
How gaming addiction affects brain activity, according to new MRI data
How opioid use disorder affects brain size and function
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.